Integrating liquid biopsies in non-small cell lung cancer diagnosis and management: opportunities and challenges | Synapse
February 11, 2026
Integrating liquid biopsies in non-small cell lung cancer diagnosis and management: opportunities and challenges
Puntos clave
This research examines the integration of liquid biopsies in diagnosing and managing non-small cell lung cancer (NSCLC).
Review of current literature on liquid biopsies in NSCLC
Analysis of challenges in standardization and clinical integration
Assessment of cost implications for clinical use
Liquid biopsies show promise for enhancing diagnostic precision in NSCLC.
Standardization issues hinder widespread adoption of liquid biopsy techniques.
Cost remains a significant barrier to implementing liquid biopsies in routine care.
Resumen
While significant progress has been made integrating liquid biopsies in NSCLC, challenges persist, encompassing issues of standardization, cost, and clinical integration.